Log In
Print this Print this

Oncophage, vitespen (Prophage) (formerly HSPPC-96)

  Manage Alerts
Collapse Summary General Information
Company Agenus Inc.
DescriptionVaccine containing the gp96 heat shock protein and associated peptides that are purified from autologous tumor cells
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityActive immunotherapy

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today